Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Integrins in Cancer Treatment

Volume:6   Issue: 2
Pp: 89-105
Johannes A. Eble and Jorg Haier
DOI: 10.2174/156800906776056518

Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma open access plus

Volume:6   Issue: 2
Pp: 123-133
A. Nardin, M. L. Lefebvre, K. Labroquere, O. Faure and J. P. Abastado
DOI: 10.2174/156800906776056473

Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?

Volume:6   Issue: 2
Pp: 147-180
F. Pendino, I. Tarkanyi, C. Dudognon, J. Hillion, M. Lanotte, J. Aradi and E. Segal-Bendirdjian
DOI: 10.2174/156800906776056482